InsidersTradesSigma
Follow the 百诚医药 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 百诚医药 has published 2 insider filings. Market capitalisation: €4.2bn. The latest transaction was filed on 1 December 2025 (Sale). Among the most active insiders: 严洪兵. All data is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€17,015
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,593 of 29,064 companies
20.2
score / 100
Value16
Quality25
FCF yld-6.0%
Earn yld-2.2%
EV/EBITDA57.9x
ROE-2.0%
Gross mgn40%
Net mgn-13%
Debt/EBITDA10.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 December 2025
关于 百诚医药
百诚医药是一家专注于医疗保健和制药领域的公司，提供与医疗保健相关的产品和服务。该公司在XSHE市场上市。